Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Authors of this article:

Shu Li^{1, 2} ;   Yupeng Xu^{2, 3} ;   Yan Xu^{2, 3} ;   Xun Xu^{2, 3}